THC BioMed Turns a Profit and Exceeds $1,000,000 in Revenue in First Quarter of 2020. CSE.THC […] Do you like it? 0. Read more. November 25, 2019. THC BioMed to Announce Annual and First Quarter Financial Results THC Kiss – THC BioMed Plant Science THC Kiss promises to deliver where all other similar products have failed. It is a one of a kind beverage that is developed from a unique extraction method, allowing the enhancement of cannabinoids that have not been utilized before. Patients – THC BioMed Plant Science We also supply 21 strains of clones for those with personal production licenses. We want to support home growers in this process and by signing up with THC BioMed you are not only receiving high quality genetics but also our support throughout the process. Genetic Strains – THC BioMed Plant Science
THC Biomed Intl Ltd. Registered Shares o.N. WKN. A14RM7. ISIN. CA87243W1032. Symbol. TFHD. Land. Kanada. Unternehmen. THC BIOMED INTL
THC BioMed Intl Ltd. ist ein Unternehmen in der Entwicklungsphase. Das Unternehmen beschäftigt sich mit der wissenschaftlichen Forschung und Entwicklung sowie dem Anbau von medizinischem Marihuana in Kanada.
Improving Nature's Product in a Responsible Manner.
THC BioMed THC BioMed News & Articles – THC BioMed Plant Science THC BioMed Turns a Profit and Exceeds $1,000,000 in Revenue in First Quarter of 2020. CSE.THC […] Do you like it? 0. Read more. November 25, 2019. THC BioMed to Announce Annual and First Quarter Financial Results
The issuer is a licensed producer and engaged in the business of developing technologies, products and services to support the Cannabis industry.
16 Oct 2019 THC BioMed Intl Ltd. announces that Health Canada has amended its licence to enable 9 Aug 2018 PRNewswire/ - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE:THC) announces that it has developed a cannabis beverage that mimics Get the latest THC Biomed INTL stock price and detailed information including news, historical charts and realtime prices.